SOURCE: Industrial Info Resources

Industrial Info Resources

January 20, 2015 06:15 ET

Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Jan 20, 2015) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the first quarter of 2015 gathers steam, the Pharmaceutical-Biotech Industry is projected to launch $3.9 billion worth of North American projects through the end of March. A healthy cash injection of that magnitude is cause for jubilation, or at the least, cautious optimism.

Within this article: Details on the industry's North American kickoffs in first-quarter 2015, including major projects from AstraZeneca (NYSE:AZN), Gilead Sciences (NASDAQ:GILD) and the U.S. Army Public Health Command.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    William Ploch